Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study. - Zhang, Ying; Numata, Kazushi; Imajo, Kento; Uojima, Haruki; Funaoka, Akihiro; Komiyama, Satoshi; Ogushi, Katsuaki; Chuma, Makoto; Irie, Kuniyasu; Kokubu, Shigehiro; Yoneda, Masato; Kobayashi, Takashi; et al. (Hepatology Research, 2024)